Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-trimester termination of pregnancy with mifepristone and varying starting doses of misoprostol
NL-OMON25409Recruiting
- Sponsor
- Divisie Gynaecologie
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mifepristone and misoprostol in pregnancy (3 arms), sponsored by Divisie Gynaecologie. Primary endpoints: Patient self-assessed side effects, Antiemetic use incidence and 2 more. Started Jul 2006; status: recruiting.
02
Drugs
mifepristonemisoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on NL-OMON25409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25409.